These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29101210)

  • 21. Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins.
    Richardson JP; Brown R; Kichik N; Lee S; Priest E; Mogavero S; Maufrais C; Wickramasinghe DN; Tsavou A; Kotowicz NK; Hepworth OW; Gallego-Cortés A; Ponde NO; Ho J; Moyes DL; Wilson D; D'Enfert C; Hube B; Naglik JR
    mBio; 2022 Feb; 13(1):e0351021. PubMed ID: 35073742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin interacts with candidalysin and neutralizes its cytotoxicity to oral epithelial cells.
    Domae E; Kamada A; Yoshikawa Y; Ikeo T
    J Oral Biosci; 2023 Jun; 65(2):206-210. PubMed ID: 36963631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candidalysin is a fungal peptide toxin critical for mucosal infection.
    Moyes DL; Wilson D; Richardson JP; Mogavero S; Tang SX; Wernecke J; Höfs S; Gratacap RL; Robbins J; Runglall M; Murciano C; Blagojevic M; Thavaraj S; Förster TM; Hebecker B; Kasper L; Vizcay G; Iancu SI; Kichik N; Häder A; Kurzai O; Luo T; Krüger T; Kniemeyer O; Cota E; Bader O; Wheeler RT; Gutsmann T; Hube B; Naglik JR
    Nature; 2016 Apr; 532(7597):64-8. PubMed ID: 27027296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of Candida albicans candidalysin ECE1 gene in oral carcinogenesis.
    Engku Nasrullah Satiman EAF; Ahmad H; Ramzi AB; Abdul Wahab R; Kaderi MA; Wan Harun WHA; Dashper S; McCullough M; Arzmi MH
    J Oral Pathol Med; 2020 Oct; 49(9):835-841. PubMed ID: 32170981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidalysin Is a Potent Trigger of Alarmin and Antimicrobial Peptide Release in Epithelial Cells.
    Ho J; Wickramasinghe DN; Nikou SA; Hube B; Richardson JP; Naglik JR
    Cells; 2020 Mar; 9(3):. PubMed ID: 32178483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candida albicans-epithelial interactions and induction of mucosal innate immunity.
    Naglik JR; König A; Hube B; Gaffen SL
    Curr Opin Microbiol; 2017 Dec; 40():104-112. PubMed ID: 29156234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungal burden, dimorphic transition and candidalysin: Role in Candida albicans-induced vaginal cell damage and mitochondrial activation in vitro.
    Spaggiari L; Ardizzoni A; Ricchi F; Pedretti N; Squartini Ramos CA; Squartini Ramos GB; Kenno S; De Seta F; Pericolini E
    PLoS One; 2024; 19(5):e0303449. PubMed ID: 38768097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second-Generation Antidiabetic Sulfonylureas Inhibit Candida albicans and Candidalysin-Mediated Activation of the NLRP3 Inflammasome.
    Lowes DJ; Hevener KE; Peters BM
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.
    Chu H; Duan Y; Lang S; Jiang L; Wang Y; Llorente C; Liu J; Mogavero S; Bosques-Padilla F; Abraldes JG; Vargas V; Tu XM; Yang L; Hou X; Hube B; Stärkel P; Schnabl B
    J Hepatol; 2020 Mar; 72(3):391-400. PubMed ID: 31606552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Candida albicans translocation through the intestinal epithelial barrier is promoted by fungal zinc acquisition and limited by NFκB-mediated barrier protection.
    Sprague JL; Schille TB; Allert S; Trümper V; Lier A; Großmann P; Priest EL; Tsavou A; Panagiotou G; Naglik JR; Wilson D; Schäuble S; Kasper L; Hube B
    PLoS Pathog; 2024 Mar; 20(3):e1012031. PubMed ID: 38427950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidalysin amplifies the immune inflammatory response in Candida albicans keratitis through the TREM-1/DAP12 pathway.
    Hu L; Bai G; Xu Q; Zhao G; Jiang N; Yao H; Liu X; Du Z
    Int Immunopharmacol; 2023 Jun; 119():110195. PubMed ID: 37087869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis.
    Chiang LY; Sheppard DC; Bruno VM; Mitchell AP; Edwards JE; Filler SG
    Cell Microbiol; 2007 Jan; 9(1):233-45. PubMed ID: 16939537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candidalysin: Connecting the pore forming mechanism of this virulence factor to its immunostimulatory properties.
    Russell CM; Rybak JA; Miao J; Peters BM; Barrera FN
    J Biol Chem; 2023 Feb; 299(2):102829. PubMed ID: 36581211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isotope labeled 3D-Raman confocal imaging and atomic force microscopy study on epithelial cells interacting with the fungus Candida albicans.
    Stanca SE; Mogavero S; Fritzsche W; Krafft C; Hube B; Popp J
    Nanomedicine; 2024 Jul; 59():102750. PubMed ID: 38734040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global fungal-host interactome mapping identifies host targets of candidalysin.
    Zhang TY; Chen YQ; Tan JC; Zhou JA; Chen WN; Jiang T; Zha JY; Zeng XK; Li BW; Wei LQ; Zou Y; Zhang LY; Hong YM; Wang XL; Zhu RZ; Xu WX; Xi J; Wang QQ; Pan L; Zhang J; Luan Y; Zhu RX; Wang H; Chen C; Liu NN
    Nat Commun; 2024 Feb; 15(1):1757. PubMed ID: 38413612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Biophysical Characterization of Candidalysin: A Fungal Peptide Toxin.
    Lee S; Kichik N; Hepworth OW; Richardson JP; Naglik JR
    Methods Mol Biol; 2022; 2542():163-176. PubMed ID: 36008664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genome-scale screen identifies sulfated glycosaminoglycans as pivotal in epithelial cell damage by
    Lin J; Miao J; Schaefer KG; Russell CM; Pyron RJ; Zhang F; Phan QT; Solis-Swidergall NV; Liu H; Tashiro M; Dordick JS; Linhardt RJ; Yeaman MR; King GM; Barrera FN; Peters BM; Filler SG
    bioRxiv; 2024 May; ():. PubMed ID: 38826446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin Neutralizes Hydrophobic Toxins and Modulates
    Austermeier S; Pekmezović M; Porschitz P; Lee S; Kichik N; Moyes DL; Ho J; Kotowicz NK; Naglik JR; Hube B; Gresnigt MS
    mBio; 2021 Jun; 12(3):e0053121. PubMed ID: 34154403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida albicans and candidalysin in inflammatory disorders and cancer.
    Ho J; Camilli G; Griffiths JS; Richardson JP; Kichik N; Naglik JR
    Immunology; 2021 Jan; 162(1):11-16. PubMed ID: 32880925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.
    Rane HS; Hardison S; Botelho C; Bernardo SM; Wormley F; Lee SA
    Virulence; 2014; 5(8):810-8. PubMed ID: 25483774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.